Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Rbv Hcv'

Rbv Hcv published presentations and documents on DocSlides.

PEG alfa-2a RBV versus

PEG alfa-2a RBV versus

  • alexa-scheidler
  • 0 Slides

. PEG alfa-. 2a . versus. INF RBV . APRICOT S...

Daclatasvir + Sofosbuvir + RBV in GT3

Daclatasvir + Sofosbuvir + RBV in GT3

  • sophia2
  • 9 Slides

. with Advanced Liver Disease. ALLY-3+ Study. Phas...

Future HCV Treatment Paradigms

Future HCV Treatment Paradigms

  • kittie-lecroy
  • 48 Slides

Mark Sulkowski, MD . Professor of Medicine. Medic...

Prevention strategies for HIV/HCV co infection

Prevention strategies for HIV/HCV co infection

  • giovanna-bartolotta
  • 0 Slides

Isabelle Andrieux-Meyer, MD. Médecins Sans Front...

HCV Clinical Management TRAINER(S)

HCV Clinical Management TRAINER(S)

  • danika-pritchard
  • 0 Slides

IAPAC African Regional Capacity-Building Hub. Bas...

HCV Clinical Management TRAINER(S)

HCV Clinical Management TRAINER(S)

  • trish-goza
  • 0 Slides

IAPAC African Regional Capacity-Building Hub. Bas...

Out With the Old and In With the New, Again?

Out With the Old and In With the New, Again?

  • test
  • 37 Slides

Out With the Old, In With the New. Current Standa...

Edited by

Edited by

  • celsa-spraggs
  • 137 Slides

Morris Sherman MD . BCh. PhD FRCP(C) . Associate...

HIV and HCV Update for the Pharmacist – June 2014

HIV and HCV Update for the Pharmacist – June 2014

  • marina-yarberry
  • 60 Slides

John J. . Faragon. , . PharmD. , BCPS, AAHIV-P. R...

Current strategies for the management of treatment naïve a

Current strategies for the management of treatment naïve a

  • min-jolicoeur
  • 60 Slides

Mark S. Sulkowski, MD. Medical Director, Viral He...

TURQUOISE-I

TURQUOISE-I

  • natalia-silvester
  • 5 Slides

OBV/PTV/r + . DSV . + RBV. OBV/PTV/r + . DSV . + ...

Hepatitis C Drug Pipeline

Hepatitis C Drug Pipeline

  • cheryl-pisano
  • 36 Slides

HCV WORLD CAB .  FEBRUARY 2014. BANGKOK, THAI...

Direct Acting Antivirals: What are they? What is their pl

Direct Acting Antivirals: What are they? What is their pl

  • tawny-fly
  • 28 Slides

Mark Sulkowski, MD. Associate Professor of Medici...

TURQUOISE-I

TURQUOISE-I

  • marina-yarberry
  • 11 Slides

OBV/PTV/r + . DSV . + RBV. OBV/PTV/r + . DSV . + ...

PEG alfa-2a +

PEG alfa-2a +

  • tawny-fly
  • 8 Slides

RBV . versus. . PEG alfa-. 2a . versus. INF + R...

SAPPHIRE-I

SAPPHIRE-I

  • ellena-manuel
  • 8 Slides

Feld JJ. NEJM . 2014;370:1594-1603. SAPPHIRE-I . ...

Peginterferon alfa-2a +

Peginterferon alfa-2a +

  • stefany-barnette
  • 8 Slides

RBV . versus. Interferon alfa. -. 2a + RBV . ACT...

OBV/PTV/r DSV RBV OBV/PTV/r

OBV/PTV/r DSV RBV OBV/PTV/r

  • ellena-manuel
  • 0 Slides

DSV . placebo. Randomisation*. Partial blind. 1...

Management of Patients with Chronic Hepatitis C: The Route to Safe and Effective Care

Management of Patients with Chronic Hepatitis C: The Route to Safe and Effective Care

  • lois-ondreau
  • 0 Slides

Sameh W. Boktor, MD, MPH. Medical Epidemiologist....

Updates in Treatment of Hepatitis C

Updates in Treatment of Hepatitis C

  • myesha-ticknor
  • 0 Slides

Gene LeSage, MD, FACP, AGAF. Objectives. HCV epid...

Updates in Treatment of Hepatitis C

Updates in Treatment of Hepatitis C

  • cheryl-pisano
  • 0 Slides

Gene LeSage, MD, FACP, AGAF. Objectives. HCV epid...

Hepatitis C Imtiaz Alam, M.D.

Hepatitis C Imtiaz Alam, M.D.

  • olivia-moreira
  • 0 Slides

Medical Director, Austin Hepatitis Center. 1. Hep...

Management of Patients with Chronic Hepatitis C: The Route to Safe and Effective Care

Management of Patients with Chronic Hepatitis C: The Route to Safe and Effective Care

  • webraph
  • 50 Slides

Sameh W. Boktor, MD, MPH. Medical Epidemiologist. ...

FISSION Design Objective

FISSION Design Objective

  • travis
  • 6 Slides

Non . inferiority. of SOF + RBV : SVR. 12. (. 2-...

Update on the HCV Antiviral Pipeline

Update on the HCV Antiviral Pipeline

  • natalia-silvester
  • 14 Slides

Todd S. Wills, MD. SPNS HCV Treatment Expansion I...

Management of HCV in Co-Infected Patients

Management of HCV in Co-Infected Patients

  • danika-pritchard
  • 22 Slides

Marie-Louise Vachon, MD, . MSc. Division of . Inf...

Use of HCV DAAs with HIV Regimens

Use of HCV DAAs with HIV Regimens

  • robaut
  • 13 Slides

Sam Lam, . PharmD. Annie Vong, . PharmD. 2/3/2017....

HIV-HCV Coinfection in the era of effective antiviral therapy

HIV-HCV Coinfection in the era of effective antiviral therapy

  • mia
  • 21 Slides

Mark Sulkowski, . MD. Professor of Medicine. Medic...

EASL 2019 HCV Conference Update

EASL 2019 HCV Conference Update

  • sophia
  • 54 Slides

April 10. –14. , 2019. Vienna, Austria. Disclaim...

MK3 MK3 + RBV

MK3 MK3 + RBV

  • min-jolicoeur
  • 10 Slides

Randomisation. Open-label. W8. * Liver biopsy or ...

SOF + EBR + GZR + RBV

SOF + EBR + GZR + RBV

  • test
  • 4 Slides

N = 12. N = 13. W24. W16. SOF + EBR + GZR + RBV. ...

SOF + RBV

SOF + RBV

  • debby-jeon
  • 7 Slides

SOF + RBV. Randomisation*. 1 : 1 : 1. Open-label....

C-WORTHY Study Part D: grazoprevir + elbasvir + RBV in genotype 3

C-WORTHY Study Part D: grazoprevir + elbasvir + RBV in genotype 3

  • UnicornLove
  • 7 Slides

C-WORTHY/D. GZR + EBR + RBV. GZR + EBR + RBV. N =...

HCV cure by IFN-free DAAs is associated with increased survival in patients with HCV-related HCC

HCV cure by IFN-free DAAs is associated with increased survival in patients with HCV-related HCC

  • jovita
  • 18 Slides

Hansen Dang,. 1,2*. Yee Hui Yeo,. 1*. Satoshi Ya...

HCV Assays: Impact on HCV Studies

HCV Assays: Impact on HCV Studies

  • blanko
  • 14 Slides

& . Update on HCV . blood bank protocol. . Ov...

State of the Art Therapy for HCV

State of the Art Therapy for HCV

  • liane-varnes
  • 56 Slides

Last Updated: February . 21, 2014. Robert G. Gish...

3 D (Paritaprevir

3 D (Paritaprevir

  • myesha-ticknor
  • 13 Slides

-Ritonavir. -Ombitasvir . + Dasabuvir) . + RBV in...

C-SCAPE

C-SCAPE

  • pasty-toler
  • 14 Slides

Design. C-SCAPE . Study. : . grazoprevir. ± . e...

SIRIUS

SIRIUS

  • tawny-fly
  • 10 Slides

Placebo. LDV/SOF + placebo. Randomisation*. 1 : 1...

Dore G. J

Dore G. J

  • pasty-toler
  • 10 Slides

Hepatol. 2016; 64:19-28. MALACHITE. TVR + PEG-IF...

Copyright © 2024 DocSlides. All Rights Reserved